http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103845730-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-04
filingDate 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2015-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-103845730-B
titleOfInvention Anti-ST2/IL-1 R4 antibody is preparing the purposes in analgesic
abstract The present invention relates to analgesic field, do you be specifically related to anti-ST2/IL-1? R4 antibody is preparing the application in analgesic, confirm through experiment, anti-ST2/IL-1 of the present invention? R4 antibody thermal hyperalgesia that is irritated to the crymodynia of neuropathic pain mouse model and cancer pain mice has significant inhibitory action.Can be used as effective ingredient, prepare analgesic further, for clinical treatment chronic pain, especially treat neuropathic pain or cancer pain.
priorityDate 2012-12-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25556
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452041512
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID17082
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507060
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6335612
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID40527
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9829
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23692753
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID72685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452115392
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID9173
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID407649
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3763

Total number of triples: 24.